Evidence map›Paper›PMID 33991188›Full record

ArticleNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2021

Studying the Utility of Using Genetics to Predict Smoking-Related Outcomes in a Population-Based Study and a Selected Cohort.

Michael J Bray, Li-Shiun Chen, Louis Fox, Yinjiao Ma, Richard A Grucza, Sarah M Hartz, Robert C Culverhouse, Nancy L Saccone, Dana B Hancock, Eric O Johnson and 3 more

Open access · greenAbstract read
In one paragraph

Article in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Michael J BrayDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Li-Shiun ChenDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Louis FoxDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Yinjiao MaDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Richard A GruczaDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Sarah M HartzDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-5429-3799
Robert C CulverhouseDepartment of Medicine, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-4480-4970
Nancy L SacconeDivision of Biostatistics, Washington University School of Medicine, St. Louis, MO, USA.
Dana B HancockGenOmics, Bioinformatics, and Translational Research Center, Biostatistics and Epidemiology Division, RTI International, Research Triangle Park, NC, USA.ORCID 0000-0003-2240-3604
Eric O JohnsonGenOmics, Bioinformatics, and Translational Research Center, Biostatistics and Epidemiology Division, RTI International, Research Triangle Park, NC, USA.
James D McKayGenetic Cancer Susceptibility Group, International Agency for Research on Cancer, World Health Organization, Lyon, France.
Timothy B BakerDepartment of Medicine, Center for Tobacco Research and Intervention, University of Wisconsin, School of Medicine and Public Health, Madison, WI, USA.
Laura J BierutDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Washington University in St. Louis · USRTI International · USCentre international de recherche sur le cancer · FRUniversity of Wisconsin–Madison · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Translating Molecular and Clinical Data to Population Lung Cancer Risk AssessmentU19CA203654 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Christopher I. Amos · 2017 to 2026
$23.7M
Enhancing the Effectiveness of Varenicline Based Smoking Cessation TreatmentR01HL109031 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI BAKER, TIMOTHY B, STEIN, JAMES H · 2011 to 2020
$17.5M
Training in the Genetics and Molecular Biology of Mental DisordersT32MH014677 · NIMH · WASHINGTON UNIVERSITY · PI RICE, JOHN P. · 1985 to 2020
$3.6M
Integrating Epigenomics in Human Brain and Genomics of Nicotine DependenceR01DA042090 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI HANCOCK, DANA B · 2016 to 2020
$3.5M
Nicotine Dependence to Smoking Cessation: Sequencing Common and Rare VariantsR01DA036583 · NIDA · WASHINGTON UNIVERSITY · PI BIERUT, LAURA J. · 2014 to 2017
$3.0M
GWA for Gene-Environment Interaction Effects Influencing CHDU01HG004402 · NHGRI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BOERWINKLE, ERIC A. · 2007 to 2009
$1.6M
Identifying gene-by-environment interplay in health behaviorR56AG058726 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GALAMA, TITUS JOHANNES · 2020 to 2020
$842k
SMOKING, SUICIDE AND MENTAL HEALTH: USING POLICY CHANGE TO PROBE CAUSALITYR01DA042195 · NIDA · WASHINGTON UNIVERSITY · PI GRUCZA, RICHARD A · 2016 to 2018
$676k
NCATS NIH HHS UL1 TR002345NCI NIH HHS P30 CA091842NCI NIH HHS U19 CA203654NHGRI NIH HHS U01 HG004402NHLBI NIH HHS HHSN268201700001CNHLBI NIH HHS HHSN268201700001INHLBI NIH HHS HHSN268201700002CNHLBI NIH HHS HHSN268201700002INHLBI NIH HHS HHSN268201700003CNHLBI NIH HHS HHSN268201700003INHLBI NIH HHS HHSN268201700004CNHLBI NIH HHS HHSN268201700004INHLBI NIH HHS HHSN268201700005CNHLBI NIH HHS HHSN268201700005INHLBI NIH HHS R01 HL109031NIA NIH HHS R56 AG058726NIDA NIH HHS R01 DA036583NIDA NIH HHS R01 DA042090NIDA NIH HHS R01 DA042195NIMH NIH HHS T32 MH014677World Health Organization 001
6 · The paper itself

Abstract

introductionThe purpose of this study is to examine the predictive utility of polygenic risk scores (PRSs) for smoking behaviors. AIMS AND

methodsUsing summary statistics from the Sequencing Consortium of Alcohol and Nicotine use consortium, we generated PRSs of ever smoking, age of smoking initiation, cigarettes smoked per day, and smoking cessation for participants in the population-based Atherosclerosis Risk in Communities (ARIC) study (N = 8638), and the Collaborative Genetic Study of Nicotine Dependence (COGEND) (N = 1935). The outcomes were ever smoking, age of smoking initiation, heaviness of smoking, and smoking cessation.

resultsIn the European ancestry cohorts, each PRS was significantly associated with the corresponding smoking behavior outcome. In the ARIC cohort, the PRS z-score for ever smoking predicted smoking (odds ratio [OR]: 1.37; 95% confidence interval [CI]: 1.31, 1.43); the PRS z-score for age of smoking initiation was associated with age of smoking initiation (OR: 0.87; 95% CI: 0.82, 0.92); the PRS z-score for cigarettes per day was associated with heavier smoking (OR: 1.17; 95% CI: 1.11, 1.25); and the PRS z-score for smoking cessation predicted successful cessation (OR: 1.24; 95% CI: 1.17, 1.32). In the African ancestry cohort, the PRSs did not predict smoking behaviors.

conclusionsSmoking-related PRSs were associated with smoking-related behaviors in European ancestry populations. This improvement in prediction is greatest in the lowest and highest genetic risk categories. The lack of prediction in African ancestry populations highlights the urgent need to increase diversity in research so that scientific advances can be applied to populations other than those of European ancestry. IMPLICATIONS: This study shows that including both genetic ancestry and PRSs in a single model increases the ability to predict smoking behaviors compared with the model including only demographic characteristics. This finding is observed for every smoking-related outcome. Even though adding genetics is more predictive, the demographics alone confer substantial and meaningful predictive power. However, with increasing work in PRSs, the predictive ability will continue to improve.

Indexed as

Multifactorial InheritanceTobacco Use DisorderHumansRisk FactorsSmokingTobacco Smoking

Identifiers

PMID33991188
PMCPMC8570670
OpenAlexW3162412519

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.